Table IX.
Metal/ceramic composites used for scaffold fabrication and their properties.
Metal/ceramic | Study | Porosity (%) | Pore size (μm) | Compressive strength (CST), Yield stress (YS) (MPa) | Compressive modulus (CM), Young’s modulus (YM) (GPa) | Ref. |
---|---|---|---|---|---|---|
SiO2/CaO/Na2O/MgO/B2O3 | 110–550 | (0.6–1)-CST | [202] | |||
Average pore size 325 | ||||||
Niobium/fluorapatite | In vitro | Macroporous structure | [325] | |||
Ti-HA | In vitro | [244] | ||||
TiO2 | In vitro/in vivo | 91 | > 1.2-CST | [191] | ||
ZrO2–CP/PCL | In vitro | 78 vol | 12.7-CST | [237] | ||
K/Sr–CPP(calcium polyphosphate) | In vitro | 40 | 1.51 ± 0.47–2.40 ± 0.27-CST | [241] | ||
ZrO2/HAp | In vitro/in vivo | 72–91 | 2.5 to 13.8-CST | [225] | ||
Porous cobalt-containing mesopore-Bioglass (Co-MBG) | In vitro | Macroporous 300–500 mesoporous 0.0045–0.005 | [234] | |||
Copper (Cu)-containing mesoporous bioactive glass (Cu-MBG) | Macroporous 300–500 mesopores 0.0038–0.0052 | [243] | ||||
β-TCP/Mg | In vitro | 42 y 50 | 500 | 8–12-CST | 0.3–0.6–CM | [230] |
90.72-YS | 15.41-YM | |||||
Sr/calcium polyphosphate (CPP) | In vitro | Irregular porosity | [239] |